Calcium phosphate crystal-associated proteins: α2-HS-glycoprotein, prothrombin F1, and osteopontin

Molecular Urology

Volumn 4, Issue 4, 2000, Pages 383-389

  Nishio, S ^a   Hatanaka, M ^a   Takeda, H ^a   Aoki, K ^a   Iseda, T ^a   Iwata, H ^a   Yokoyama, M ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CALCIUM OXALATE; CALCIUM PHOSPHATE; GLYCOPROTEIN; GLYCOPROTEIN ALPHA2 HS; OSTEOPONTIN; PROTHROMBIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; HUMAN; HUMAN TISSUE; NORMAL HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECURRENT DISEASE; SEQUENCE ANALYSIS; STONE FORMATION; URINARY EXCRETION; URINE LEVEL; UROLITHIASIS;

ADOLESCENT; ADULT; AGED; BLOOD PROTEINS; CALCIUM COMPOUNDS; CALCIUM PHOSPHATES; CASE-CONTROL STUDIES; CHROMATOGRAPHY, ION EXCHANGE; CRYSTALLIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; IMMUNOBLOTTING; MALE; MIDDLE AGED; OSTEOPONTIN; OXIDES; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; PROTHROMBIN; SEQUENCE ANALYSIS, PROTEIN; SIALOGLYCOPROTEINS; URINARY CALCULI;

EID: 0033636384     PISSN: 10915362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. The amount and nature of the organic matrix in urinary calculi: A review
2. Study of passed stones by means of X-rays, infrared and thermal analysis
3. Matrix glycosaminoglycan in urinary stones
4. Glycosaminoglycans content of stone matrix
5. The organic matrix of urinary uric acid crystals
6. The immunohistochemical distribution and quantification of crystal matrix protein
7. Isolation and partial characterization of crystal matrix protein as a potent inhibitor of calcium oxalate crystal aggregation: Evidence of activation peptide of human prothrombin
8. Calcium oxalate crystal matrix extract: The most potent macromolecular inhibitor of crystal growth and aggregation yet tested in undiluted human urine in vitro
9. Blood coagulation proteins and urolithiasis are linked: Crystal matrix protein is the F1 activation peptide of human prothrombin
10. Molecular cloning and sequencing of cDNA encoding urinary stone protein, which is identical to osteopontin
11. Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi
12. Localization of Tamm-Horsfall protein and osteopontin in a rat nephrolithiasis model
13. The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted urine in vitro
14. Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidney
15. The effect of osteopontin on the adhesion of calcium oxalate crystals to Madin-Darby canine kidney cells
16. Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects
17. Calcium oxalate crystallisation kinetics and the effects of calcium and γ-carboxyglutamic acid
18. Protein measurement with the folin phenol reagent
19. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
20. Modifiers of calcium oxalate crystallization found in urine I: Studies with a continuous crystallizer using an artificial urine
21. Quantification of osteopontin in the urine of healthy and stone-forming men
22. Preparation and properties of the human plasma Ba-alpha2-glycoproteins
23. Origin of plasma alpha2HS-glycoprotein and its accumulation in bone
24. Variations in the serum concentration and urine excretion of alpha 2HS-glycoprotein, a bone-related protein, in normal individuals and in patients with osteogenesis imperfecta
25. Fetuin: An old friend revisited
26. Generation of the combined prothrombin activation peptide (F1-2) during the clotting of blood and plasma
27. Blood coagulation proteins and urolithiasis are linked: Crystal matrix protein is the F1 activation peptide of human prothrombin
28. Further evidence linking urolithiasis and blood coagulation: Urinary prothrombin fragment 1 is present in stone matrix
29. Calcium oxalate crystal matrix extract: The most potent macromolecular inhibitor of crystal growth and aggregation yet tested in undiluted human urine in vitro
30. The prothrombin gene is expressed in the rat kidney: Implications for urolithiasis research
31. Quantitation of prothrombin activation products in human urine
32. Inhibition of calcium oxalate crystal growth in vitro by uropontin: Another member of the aspartic acid-rich protein superfamily
33. Osteopontin in urinary stone formation